Takahashi, K., Kantarjian, H., Yang, Y., Sasaki, K., Jain, P., DellaSala, S., . . . Cortes, J. E. (2016). A Propensity Score Matching Analysis of Dasatinib and Nilotonib as a Frontline Therapy for Patients with Chronic Myeloid Leukemia in Chronic Phase. Cancer.
استشهاد بنمط شيكاغوTakahashi, Koichi, et al. "A Propensity Score Matching Analysis of Dasatinib and Nilotonib As a Frontline Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase." Cancer 2016.
MLA استشهادTakahashi, Koichi, et al. "A Propensity Score Matching Analysis of Dasatinib and Nilotonib As a Frontline Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase." Cancer 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.